USA - NYSE:EMR - US2910111044 - Common Stock
The current stock price of EMR is 132.68 USD. In the past month the price increased by 3.17%. In the past year, price increased by 22.7%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ETN | EATON CORP PLC | 33.18 | 146.49B | ||
| VRT | VERTIV HOLDINGS CO-A | 48.71 | 71.05B | ||
| AME | AMETEK INC | 26.51 | 43.22B | ||
| ROK | ROCKWELL AUTOMATION INC | 37.25 | 40.08B | ||
| HUBB | HUBBELL INC | 25.52 | 23.08B | ||
| NVT | NVENT ELECTRIC PLC | 37.16 | 16.45B | ||
| NXT | NEXTRACKER INC-CL A | 21.04 | 14.54B | ||
| AYI | ACUITY INC | 20.44 | 11.28B | ||
| GNRC | GENERAC HOLDINGS INC | 24.11 | 11.26B | ||
| RRX | REGAL REXNORD CORP | 15.57 | 9.78B | ||
| ST | SENSATA TECHNOLOGIES HOLDING | 9.75 | 4.64B | ||
| RUN | SUNRUN INC | 9.03 | 4.81B |
Emerson Electric Co. is a global technology and software company, which engages in the provision of solutions. The company is headquartered in St. Louis, Missouri and currently employs 73,000 full-time employees. The firm operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.
EMERSON ELECTRIC CO
8027 Forsyth Boulevard,
St. Louis MISSOURI 63136 US
CEO: S. L. Karsanbhai
Employees: 73000
Phone: 13145532000
Emerson Electric Co. is a global technology and software company, which engages in the provision of solutions. The company is headquartered in St. Louis, Missouri and currently employs 73,000 full-time employees. The firm operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.
The current stock price of EMR is 132.68 USD. The price decreased by -0.38% in the last trading session.
EMERSON ELECTRIC CO (EMR) has a dividend yield of 1.64%. The yearly dividend amount is currently 2.1.
EMR has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The PE ratio for EMERSON ELECTRIC CO (EMR) is 22.64. This is based on the reported non-GAAP earnings per share of 5.86 and the current share price of 132.68 USD.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EMR.
You can find the ownership structure of EMERSON ELECTRIC CO (EMR) on the Ownership tab.
ChartMill assigns a technical rating of 3 / 10 to EMR. When comparing the yearly performance of all stocks, EMR turns out to be only a medium performer in the overall market: it outperformed 55.69% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to EMR. While EMR has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months EMR reported a non-GAAP Earnings per Share(EPS) of 5.86. The EPS increased by 10.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.92% | ||
| ROA | 6.24% | ||
| ROE | 13.35% | ||
| Debt/Equity | 0.42 |
34 analysts have analysed EMR and the average price target is 151.8 USD. This implies a price increase of 14.41% is expected in the next year compared to the current price of 132.68.
For the next year, analysts expect an EPS growth of 10.44% and a revenue growth 3.68% for EMR